Total Payments
$1,638
2024 Payments
$61.71
Companies
19
Transactions
99
Medicare Patients
1,394
Medicare Billing
$76,111
Payment Breakdown by Category
Food & Beverage$1,638 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,638 | 99 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $339.25 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $154.21 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $151.78 | 7 | $0 (2023) |
| PFIZER INC. | $142.98 | 9 | $0 (2023) |
| Novo Nordisk Inc | $130.25 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $129.31 | 8 | $0 (2022) |
| Lilly USA, LLC | $120.53 | 9 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.89 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $86.33 | 6 | $0 (2021) |
| Amgen Inc. | $51.75 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61.71 | 3 | ABBVIE INC. ($44.54) |
| 2023 | $263.59 | 13 | ABBVIE INC. ($99.90) |
| 2022 | $545.48 | 33 | ABBVIE INC. ($76.44) |
| 2021 | $767.69 | 50 | AbbVie Inc. ($118.37) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Biological | ||||||
| 09/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Biological | ||||||
| 08/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Biological | ||||||
| 05/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Urology | ||||||
| 03/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, BOOSTRIX | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: VACCINES | ||||||
| 12/01/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Urology | ||||||
| 11/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Gastroenterology | ||||||
| 11/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Diabetes | ||||||
| 10/24/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: VACCINES | ||||||
| 09/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 08/31/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 309 | 397 | $43,915 | $22,111 |
| 2022 | 7 | 330 | 349 | $43,980 | $21,660 |
| 2021 | 5 | 543 | 578 | $37,710 | $20,567 |
| 2020 | 7 | 212 | 263 | $27,865 | $11,773 |
Total Patients
1,394
Total Services
1,587
Medicare Billing
$76,111
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 219 | $35,040 | $17,082 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 43 | $4,785 | $2,198 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $1,650 | $1,151 | 69.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 78 | 100 | $1,000 | $840.00 | 84.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 12 | $900.00 | $486.60 | 54.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $540.00 | $353.40 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 139 | $22,240 | $10,346 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 101 | $11,500 | $4,950 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $4,200 | $3,009 | 71.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 24 | 24 | $2,160 | $1,616 | 74.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,170 | $707.25 | 60.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 18 | 18 | $1,350 | $689.35 | 51.1% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 13 | $1,360 | $342.39 | 25.2% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 287 | 291 | $13,095 | $7,187 | 54.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 123 | 123 | $5,535 | $4,651 | 84.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 60 | $9,600 | $4,057 | 42.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 73 | $8,085 | $3,478 | 43.0% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 31 | 31 | $1,395 | $1,194 | 85.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 86 | 122 | $13,420 | $4,577 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 54 | $8,670 | $3,718 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 15 | 15 | $1,725 | $1,365 | 79.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 19 | 19 | $1,405 | $1,159 | 82.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 13 | 16 | $1,040 | $445.59 | 42.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 25 | 25 | $1,125 | $406.67 | 36.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 12 | $480.00 | $101.10 | 21.1% |
About Kelsey Williard, PA-C
Kelsey Williard, PA-C is a Physician Assistant healthcare provider based in Sunbury, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1851829964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelsey Williard, PA-C has received a total of $1,638 in payments from pharmaceutical and medical device companies, with $61.71 received in 2024. These payments were reported across 99 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,638).
As a Medicare-enrolled provider, Williard has provided services to 1,394 Medicare beneficiaries, totaling 1,587 services with total Medicare billing of $76,111. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Sunbury, PA
- Active Since 06/02/2017
- Last Updated 10/05/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851829964
Products in Payments
- VRAYLAR (Drug) $198.98
- ELIQUIS (Drug) $144.68
- QULIPTA (Drug) $140.27
- XARELTO (Drug) $129.31
- TRULICITY (Drug) $106.57
- SHINGRIX (Biological) $87.85
- STIOLTO RESPIMAT (Drug) $82.05
- Veozah (Drug) $72.19
- Ozempic (Drug) $64.60
- FARXIGA (Drug) $59.11
- TRELEGY ELLIPTA (Drug) $52.12
- Rybelsus (Drug) $50.86
- Vascepa (Drug) $42.89
- MYRBETRIQ (Drug) $41.83
- GARDASIL 9 (Biological) $38.80
- Myrbetriq (Drug) $37.76
- Aimovig (Biological) $34.03
- TRADJENTA (Drug) $33.84
- ENTRESTO (Drug) $30.52
- BREZTRI (Drug) $27.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Sunbury
Eydie Mathews, Pa, PA
Physician Assistant — Payments: $13,372
Physician Assistant $13,372
Nicole Krebs, Paa-C, PAA-C
Physician Assistant — Payments: $5,692
Physician Assistant $5,692
Kevin Kaczmarek, Pa-C, PA-C
Physician Assistant — Payments: $498.89
Physician Assistant $498.89
Mr. David Albright, Pa-C, PA-C
Physician Assistant — Payments: $82.29
Physician Assistant $82.29
Kyle Mcmanigle, Pa-C, PA-C
Physician Assistant — Payments: $29.23
Physician Assistant $29.23
Mr. Devin Smith, Pa-C, PA-C
Physician Assistant
Physician Assistant